P2X receptors in the cardiovascular system

Wiley Interdisciplinary Reviews: Membrane Transport and Signaling

Volumn 1, Issue 5, 2012, Pages 663-674

  Ralevic, Vera ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PURINERGIC P2X RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X5 RECEPTOR; PURINERGIC P2X6 RECEPTOR; PURINERGIC P2X7 RECEPTOR;

ARTERY CONSTRICTION; ARTICLE; CARDIOVASCULAR SYSTEM; CAROTID ARTERY THROMBOSIS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HYPERTENSION; IMMUNOREACTIVITY; NEUROTRANSMISSION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; PURINERGIC P2X1 RECEPTOR GENE; PURINERGIC P2X2 RECEPTOR GENE; PURINERGIC P2X3 RECEPTOR GENE; PURINERGIC P2X4 RECEPTOR GENE; PURINERGIC P2X5 RECEPTOR GENE; PURINERGIC P2X6 RECEPTOR GENE; PURINERGIC P2X7 RECEPTOR GENE; RECEPTOR GENE; SENSORY NERVE; SYMPATHETIC FUNCTION; VASODILATATION;

EID: 84879192586     PISSN: 2190460X     EISSN: 21904618     Source Type: Journal    
DOI: 10.1002/wmts.58     Document Type: Article

References (136)

1. 3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J 1998, 17:3016-3028.
2. Jiang L-H, Kim M, Spleta V, Bo X, Surprenant A, North RA. Subunit arrangement in P2X receptors. J Neurosci 2003, 23:8903-8910.
3. 6 receptor subunits do not oligomerize. J Biol Chem 2005, 280:10759-10765.
4. Kawate T, Michel JC, Birdsong WT, Gouaux E. Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 2009, 460:592-598.
5. Li M, Kawate T, Silberberg SD, Swartz KJ. Pore-opening mechanism in trimeric P2X receptor channels. Nat Commun 2010, 1:44. doi: 10.1038/ncomms1048.
6. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Séguéla P, Voigt M, Humphrey PA. International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 2001, 53:107-118.
7. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002, 82:1013-1067.
8. Roberts JA, Vial C, Digby HR, Agboh KC, Wen H, Atterbury-Thomas A, Evans RJ. Molecular properties of P2X receptors. Pflugers Arch 2006, 542:486-500.
9. Burnstock G. Co-Transmission. The Fifth Heymans Memorial Lecture. Arch Int Pharmacodyn Ther 1990, 304:7-33.
10. Yeoh M, Brock JA. Rho kinase inhibitors reduce neurally evoked contraction of the rat tail artery in vitro. Br J Pharmacol 2005, 146:854-861.
11. Inscho EW, Cook AK, Webb RC, Jin L-M. Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter. Am J Physiol 2009, 296:F590-F597.
12. Omote S, Kigoshi S, Muramatsu I. Selective inhibition by nifedipine of the purinergic component of neurogenic vasoconstriction in the dog mesenteric artery. Eur J Pharmacol 1989, 160:239-245.
13. Gitterman DP, Evans RJ. Nerve evoked P2X receptor contractions of rat mesenteric arteries; dependence on vessel size and lack of L-type calcium channels and calcium-induced calcium release. Br J Pharmacol 2001, 132:1202-1208.
14. Rummery NM, Brock JA, Pakdeechote P, Ralevic V, Dunn WR. ATP is the predominant sympathetic neurotransmitter in rat mesenteric arteries at high pressure. J Physiol 2007, 582(Pt 2):745-754.
15. 6-like receptor in arteries. Mol Pharmacol 2002, 62:1438-1445.
16. Hansen MA, Bennett MR, Barden JA. Distribution of purinergic P2X receptors in the rat heart. J Auton Nerv Syst 1999, 78:1-9.
17. 2X (purinergic) receptor distributions in rat blood vessels. J Auton Nerv Syst 1999, 75:147-155.
18. Gitterman DP, Evans RJ. Properties of P2X and P2Y receptors are dependent on artery diameter in the rat mesenteric bed. Br J Pharmacol 2000, 131:1561-1568.
19. Lewis CJ, Evans RJ. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterisation of the properties of mesenteric artery P2X receptor ion channels. Br J Pharmacol 2000, 131:1659-1666.
20. Lewis CJ, Evans RJ. P2x receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J Vasc Res 2001, 38:332-340.
21. 1 receptor-mediated currents and arterial vasoconstriction. J Biol Chem 2005, 280:30705-30711.
22. Phillips JK, Hill CE. Neuroreceptor mRNA expression in the rat mesenteric artery develops independently of innervations. Int J Dev Neurosci 1999, 17:377-386.
23. Ralevic V, Burrell S, Kingdom J, Burnstock G. Characterization of P2 receptors for purine and pyrimidine nucleotides in human placental cotyledons. Br J Pharmacol 1997, 121:1121-1126.
24. 7 nucleotide receptors in the smooth muscle of human umbilical cord and chorionic blood vessels. Placenta 2003, 24:17-26.
25. Burnstock G, Warland JJI. A pharmacological study of the rabbit saphenous vein in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation. Br J Pharmacol 1987, 90:111-120.
26. Rump LC, von Kügelgen I. A study of ATP as a sympathetic cotransmitter in human saphenous vein. Br J Pharmacol 1994, 111:65-72.
27. 2X-purinoceptor agonist β, γ-methylene-L-ATP in human cutaneous and renal blood vessels. Br J Pharmacol 1995, 116:1932-1936.
28. Mutafova-Yambolieva V, Carolan BM, Harden TK, Keffe KD. Multiple P2Y receptors mediate contraction in guinea pig mesenteric vein. Gen Pharmacol 2000, 34:127-136.
29. Galligan JJ, Hess MC, Miller SB, Fink GD. Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats. J Pharmacol Exp Ther 2001, 296:478-485.
30. 7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ Res 1998, 83:196-203.
31. Muramatsu I, Fujiwara M, Miura A, Sakakibara Y. Possible involvement of adenine nucleotides in sympathetic neuroeffector mechanisms of dog basilar artery. J Pharmacol Exp Ther 1981, 216:401-409.
32. Katsuragi T, Su C. Purine release from vascular adrenergic nerves by high potassium and a calcium ionophore, A-23187. J Pharmacol Exp Ther 1980, 215:685-690.
33. Su C. Neurogenic release of purine compounds in blood vessels. J Pharmacol Exp Ther 1975, 195:159-166.
34. Kirkpatrick K, Burnstock G. Sympathetic nerve-mediated release of ATP from the guinea-pig vas deferens is unaffected by reserpine. Eur J Pharmacol 1987, 138:207-214.
35. Kluess HA, Stone AJ, Evanson KW. ATP overflow in skeletal muscle 1A arterioles. J Physiol 2010, 588(Pt 16):3089-3100.
36. Westfall TD, Menzies JRW, Liberman R, Waterston S, Ramphir N, Westfall DP, Sneddon P, Kennedy C. Release of a soluble ATPase from the rabbit isolated vas deferens during nerve stimulation. Br J Pharmacol 2000, 131:909-914.
37. Machida T, Heerdt PM, Reid AC, Schäfer U, Silver RB, Broekman MJ, Marcus AJ, Levi R. Ectonucleoside triphosphate and diphosphohydrolase1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis. J Pharmacol Exp Ther 2005, 313:570-577.
38. Corti F, Olson KE, Marcus AJ, Levi R. The expression level of ecto-NTP diphosphohydrolase 1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurones. J Pharmacol Exp Ther 2011, 337:524-532.
39. Sneddon P, Burnstock G. ATP as a co-transmitter in rat tail artery. Eur J Pharmacol 1984, 106:149-152.
40. Burnstock G, Kennedy C. Purinergic receptors in the cardiovascular system. Prog Pharmacol 1986, 6:111-132.
41. Donoso MV, Steiner M, Huidobro-Toro JP. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5′-triphosphate and NA as sympathetic cotransmitters in the rat arterial mesenteric bed. J Pharmacol Exp Ther 1997, 282:691-698.
42. Racchi H, Irarrázabal MJ, Howard M, Morán S, Zalaquett R, Huidobro-Toro JP. Adenosine 5′-triphosphate and neuropeptide Y are co-transmitters in conjunction with NA in the human saphenous vein. Br J Pharmacol 1999, 126:1175-1185.
43. Smyth L, Bobalova J, Ward SM, Keef KD, Mutafova-Yambolieva VN. Cotransmission from sympathetic vasoconstrictor neurons: differences in guinea-pig mesenteric artery and vein. Auton Neurosci 2000, 86:18-29.
44. Sjoblom-Widfeldt N, Gustafsson N, Nilsson H. Sympathetic transmission in small mesenteric arteries from the rat: influence of impulse pattern. Acta Physiol Scand 1990, 138:523-528.
45. Dunn WR, Brock JK, Hardy TA. Electrochemical and electrophysiological characterization of neurotransmitter release from sympathetic nerves supplying rat mesenteric arteries. Br J Pharmacol 1999, 128:174-180.
46. Ramme D, Regenold JT, Starke K, Busse R, Illes P. Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol 1987, 336:267-273.
47. Evans RJ, Surprenant A. Vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP. Br J Pharmacol 1992, 106:242-249.
48. 2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur J Pharmacol 1985, 107:161-168.
49. Kennedy C, Burnstock G. ATP causes postjunctional potentiation of noradrenergic contractions in the portal vein of guinea pig and rat. J Pharm Pharmacol 1986, 38:307-309.
50. Ralevic V, Burnstock G. Postjunctional synergism of NA and adenosine 5′-triphosphate in the mesenteric arterial bed of the rat. Eur J Pharmacol 1990, 175:291-299.
51. Zimmerman H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev Res 2001, 52:44-56.
52. Stjärne L. Basic mechanisms and local modulation of nerve impulse-induced secretion of neurotransmitters from individual sympathetic nerve varicosities. Rev Physiol Biochem Pharmacol 1989, 112:1-137.
53. Trendelenburg U. The TiPS lecture: functional aspects of the neuronal uptake of noradrenaline. Trends Pharmacol Sci 1991, 12:334-337.
54. Yamamoto R, Takasaki K, Nickols GA. Purinergic vasoconstrictor component revealed by moderate cooling in the isolated mesenteric vasculature of Sprague-Dawley rats. J Pharmacol Exp Ther 1992, 262:1133-1138.
55. Pakdeechote P, Rummery NM, Ralevic V, Dunn WR. Raised tone reveals purinergic-mediated responses to sympathetic nerve stimulation in the rat perfused mesenteric vascular bed. Eur J Pharmacol 2007, 563:180-186.
56. Stephens N, Bund SJ, Faragher EB, Heagerty AM. Neurotransmission in human resistance arteries: contribution of alpha 1- and alpha 2-adrenoceptors but not P2-purinoceptors. J Vasc Res 1992, 29:347-352.
57. 2-adrenoceptors. Br J Pharmacol 2005, 144:737-742.
58. Inoue T, Kannan MS. Nonadrenergic and noncholinergic excitatory neurotransmission in rat intrapulmonary artery. Am J Physiol Heart Circ Physiol 1988, 254:H1142-H1148.
59. Ralevic V. Purines as neurotransmitters and neuromodulators in perivascular nerves. Curr Vasc Pharmacol 2009, 7:3-14.
60. 3H]-NA release from the isolated guinea-pig right atrium by P2X-receptors located on axon terminals. Br J Pharmacol 2000, 131:1775-1783.
61. 2-purinoceptors. Naunyn Schmiedebergs Arch Pharmacol 1995, 352:17-24.
62. Boehm S. ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors. J Neurosci 1999, 19:737-746.
63. von Kügelgen I, Nörenberg W, Illes P, Schobert A, Starke K. Differences in the mode of stimulation of cultured rat sympathetic neurones between ATP and UTP. Neuroscience 1997, 78:935-941.
64. von Kügelgen I, Nörenberg W, Meyer A, Illes P, Starke K. Role of action potentials and calcium influx in ATP- and UDP-induced NA release from rat cultured sympathetic neurones. Naunyn Schmiedebergs Arch Pharmacol 1999, 359:360-369.
65. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 1996, 16:2495-2507.
66. 6 and atypical UTP-sensitive receptors coupled to rises in intracellular calcium in mouse cultured superior cervical ganglion neurons and glia. Br J Pharmacol 2004, 143:525-532.
67. 1 receptors revealed using knockout mice. Mol Pharmacol 2004, 65:139-148.
68. Koganezawa T, Ishikawa T, Fujita Y, Yamashita T, Tajima T, Honda M, Nakayama K. Local regulation of skin blood flow during cooling involving presynaptic P2 purinoceptors in rats. Br J Pharmacol 2006, 148:579-586.
69. Sperlágh B, Heinrich A, Csölle C. P2 receptor-mediated modulation of neurotransmitter release-an update. Purinergic Signal 2007, 3:269-284.
70. Burnstock G. P2X receptors in sensory neurons. Br J Anaesth 2000, 84:476-488.
71. 2B adenosine and P2X purinergic receptors. Neuroscience 2002, 110:123-129.
72. Ralevic V. Mechanism of prolonged vasorelaxation to ATP in the rat isolated mesenteric arterial bed. Br J Pharmacol 2001, 132:685-692.
73. Rubino A, Amerini S, Ledda F, Mantelli L. ATP modulates the efferent function of capsaicin-sensitive neurones in the guinea-pig isolated atria. Br J Pharmacol 1992, 105:516-520.
74. Sinoway LI, Li J. A perspective on the muscle reflex: implications for congestive heart failure. J Appl Physiol 2005, 99:5-22.
75. McCord JL, Tsuchimochi H, Kaufman MP. P2X2/3 and P2X3 receptors contribute to the metaboreceptor component of the exercise pressor reflex. J Appl Physiol 2010, 109:1416-1423.
76. O'Leary DS. Altered reflex cardiovascular control during exercise in heart failure: animal studies. Exp Physiol 2006, 91:73-77.
77. Smith SA, Mitchell JH, Garry MG. The mammalian exercise pressor reflex in health and disease. Exp Physiol 2006, 91:89-102.
78. 3 expression in DRG neurons of rats with femoral artery occlusion. Am J Physiol Heart Circ Physiol 2011, 301:H1070-H1079.
79. Vallon V. Tubuloglomerular feedback and the control of glomerular filtration rate. News Physiol Sci 2003, 18:169-174.
80. 1 knockout mice. Acta Physiol Scand 2004, 181:445-453.
81. Inscho EW, Cook AK, Clarke A, Zhang S, Guan Z. P2X1 receptor-mediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet. Hypertension 2011, 57:780-787.
82. 1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1362-R1367.
83. Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, Saunders T, Briggs J, Schnermann J. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci U S A 2001, 98:9983-9988.
84. Vulchanova L, Arvidsson U, Riedl M, Wang J, Buell G, Surprenant A, North RA. Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci U S A 1996, 93:8063-8067.
85. Mei Q, Liang BT. P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts. Am J Physiol Heart Circ Physiol 2001, 281:H334-H341.
86. 4 receptor. FASEB J 2001, 15:2739-2741. doi: 10.1096/fj.01-0445fje
87. 4 receptor is a glycosylated cardiac receptor mediating a positive inotropic response to ATP. J Biol Chem 2002, 18:15752-15757.
88. 4 receptors. FASEB J 2006, 20:277-284.
89. Sesti C, Brockman MJ, Drosopoulos JH, Islam N, Marcus AJ, Levi R. Ectonucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release. J Pharmacol Exp Ther 2002, 300:605-611.
90. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998, 50:413-492.
91. Ray FR, Huang W, Slater M, Barden JA. Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts. Atherosclerosis 2002, 162:55-61.
92. Wang L, Karlsson L, Moses S, Hultgärdh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D. P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 2002, 40:841-853.
93. Schwiebert LM, Rice WC, Kudlow BA, Taylor AL, Schwiebert EM. Extracellular ATP signalling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. Am J Physiol Cell Physiol 2002, 282:C289-C301.
94. 6 receptors associated with VE-cadherin in human endothelial cells. Cell Mol Life Sci 2002, 59:870-881.
95. Wilson HL, Varcoe RW, Stokes L, Holland KL, Francis SE, Dower SK, Surprenant A, Crossman DC. P2X receptor characterization and IL-1/IL-1Ra release from human endothelial cells. Br J Pharmacol 2007, 151:96-108.
96. Wu T, Dai M, Shi XR, Jiang ZG, Nuttall AL. Functional expression of P2X4 receptor in capillary endothelial cells of the cochlear spiral ligament and its role in regulating the capillary diameter. Am J Physiol Heart Circ Physiol 2011, 301:H69-H78.
97. 2 receptor immunoreactivity in vascular endothelial cells in rat brain. Endothelium 2000, 7:93-98.
98. Glass R, Townsend-Nicholson A, Burnstock G. P2 receptors in the thymus: expression of P2X and P2Y receptors in adult rats, an immunohistochemical and in situ hybridisation study. Cell Tissue Res 2000, 300:295-306.
99. Glass R, Burnstock G. Immunohistochemical identification of cells expressing ATP-gated cation channels (P2X receptors) in the adult rat thyroid. J Anat 2001, 198:569-579.
100. Ramirez A, Kunze DL. P2X purinergic receptor channel expression and function in bovine aortic endothelium. Am J Physiol Heart Circ Physiol 2002, 282:H2106-H2116.
101. 4 purinoceptors. Circ Res 2000, 87:385-391.
102. 4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol Heart Circ Physiol 2000, 279:H285-H292.
103. 4 receptor gene transcription in endothelial cells exposed to shear stress. Am J Physiol 2001, 280:H2214-H2221.
104. 4-deficient mice. Nat Med 2006, 12:133-137.
105. 4-receptor gene expression by interferon-γ in vascular endothelial cells. J Pharmacol Sci 2008, 107:419-427.
106. 2+ mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells. Cell Calcium 2011, 49:240-246.
107. Bergfeld GR, Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 1992, 26:40-47.
108. Ellsworth ML, Forrester T, Ellis CG, Dietrich HH. The erythrocyte as a regulator of vascular tone. Am J Physiol 1995, 269:H2155-H2161.
109. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol 1996, 271:H2717-H2722.
110. Yang S, Cheek DJ, Westfall DP, Buxton IL. Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res 1994, 74:401-407.
111. Buxton ILO, Kaiser RA, Oxhorn BC, Cheek DJ. Evidence supporting the nucleotide axis hypothesis: ATP release and metabolism by coronary endothelium. Am J Physiol 2001, 281:H1657-H1666.
112. Harrington LS, Mitchell JA. Novel role for P2X receptor activation in endothelium-dependent vasodilation. Br J Pharmacol 2004, 143:611-617.
113. 1 receptors mediate endothelial dependent vasodilation to ATP. Mol Pharmacol 2007, 72:1132-1136.
114. Silva CLM, Tamura EK, Macedo SMD, Cecon E, Bueno-Alves L, Farsky SHP, Ferreira ZS, Markus RP. Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro. Br J Pharmacol 2007, 151:195-205.
115. Shen J-B, Cronin C, Sonin D, Joshi BV, Nieto MG, Harrison D, Jacobson KA, Liang BT. P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure. Am J Physiol Heart Circ Physiol 2007, 292:H1077-H1084.
116. Zhou S-Y, Mamdani M, Qanud K, Shen J-B, Pappano AJ, Kumar TS, Jacobson KA, Hintze T, Recchia FA, Liang BT. Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implications for a role of cardiac purinergic P2X receptors. J Pharmacol Exp Ther 2010, 333:920-928.
117. 3 receptor in myocardial ischemia injury and nociceptive sensory transmission. Auton Neurosci 2008, 139:30-37.
118. 4 receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathy. Am J Physiol Heart Circ Physiol 2004, 287:H1096-H1103.
119. Sonin D, Zhou S-Y, Cronin C, Sonina T, Wu J, Jacobson KA, Pappano A, Laing BT. Role of P2X purinergic receptors in the rescue of ischemic heart failure. Am J Physiol Heart Circ Physiol 2008, 295:H1191-H1197.
120. 4 receptors in cardiomyopathy. Am J Physiol Heart Circ Physiol 2009, 296:H1089-H1095.
121. Vidal M, Hicks PE, Langer SZ. Differential effects of α, β-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedebergs Arch Pharmacol 1986, 332:384-390.
122. Brock JA, Van Helden DF. Enhanced excitatory junction potentials in mesenteric arteries from spontaneously hypertensive rats. Pflugers Arch 1995, 430:901-908.
123. Dalziel HH, Machaly M, Sneddon P. Comparison of the purinergic contribution to sympathetic vascular responses in SHR and WKY rats in vitro and in vivo. Eur J Pharmacol 1989, 173:9-26.
124. Muir TC, Wardle KA. Vascular smooth muscle responses in normo- and hypertensive rats to sympathetic nerve stimulation and putative transmitters. J Auton Pharmacol 1989, 9:23-34.
125. 2 inhibits NA release and purinergic pressor responses to renal nerve stimulation at 1Hz in isolated kidneys of young spontaneously hypertensive rats. J Hypertens 1990, 8:897-908.
126. Vonend O, Okonek A, Stegbauer J, Habbel S, Quack I, Rump LC. Renovascular effects of sympathetic neurotransmitters ATP ad NPY are age-dependent in spontaneously hypertensive rats. Cardiovasc Res 2005, 66:345-352.
127. Haddock RE, Hill CE. Sympathetic overdrive in obesity involves purinergic hyperactivity in the resistance vasculature. J Physiol 2011, 589(Pt 13):3289-3307.
128. Goetz V, Da Prada M, Pletscher A. Adenine-, guanine- and uridine-5′-phosphonucleotides in blood platelets and storage organelles of various species. J Pharmacol Exp Ther 1971, 178:210-215.
129. Born GVR, Kratzer MAA. Source and concentration of extracellular adenosine triphosphate during hemostasis in rats, rabbits and man. J Physiol 1984, 354:419-429.
130. Gachet C, Léon C, Hechler B. The platelet P2 receptor in arterial thrombosis. Blood Cells Mol Dis 2006, 36:223-227.
131. Hechler B, Gachet C. P2 receptors and platelet function. Purinergic Signal 2011, 7:293-303.
132. Pulvirenti TJ, Yin JL, Chaufour X, McLachlan C, Hambly BD, Bennett MR, Barden JA. P2X (purinergic) receptor redistribution in rabbit aorta following injury to endothelial cells and cholesterol feeding. J Neurocytol 2000, 29:623-631.
133. 7 receptor. J Physiol 1999, 519(Pt 2):335-346.
134. Sylte MJ, Kuckleburg CJ, Inzana TJ, Bertics PJ, Czuprynski CJ. Stimulation of P2X receptors enhances lipooligosaccharide-mediated apoptosis of endothelial cells. J Leukoc Biol 2005, 77:958-965.
135. Metcalfe MJ, Baker DM, Turmaine M, Burnstock G. Alterations in purinoceptor expression in human long saphenous vein during varicose disease. Eur J Endovasc Surg 2007, 33:239-250.
136. Furlan-Freguia C, Marchese P, Gruber A, Ruggeri Z, Ruf W. P2X7 receptor signalling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest 2011, 121:2932-2944.